Researchers conducted a retrospective cohort study involving fee-for-service Medicare beneficiaries admitted with COPD exacerbation, HF exacerbation or a heart attack from 2010 to 2012. In all, researchers investigated 1.55 million Medicare beneficiaries with the aforementioned conditions.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox
Here are three insights:
1. Admission to the ICU was not associated with significant differences in 30-day mortality rates for any of the three conditions.
2. ICU admission was associated with significantly greater hospital costs for HF exacerbation or heart attacks, but not COPD.
3. ICU admission did not confer a survival benefit for patients with these conditions.
More articles on healthcare quality:
Study: Zika virus persisted in semen for 3 months in 95% of men
How far do germs travel after a sneeze? It’s farther than you think
Michigan health officials order McLaren Flint Hospital to address Legionella issues
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
